Alexis Kern

In bringing Winlevi to market, we wanted to create a campaign that would work across both HCP and Patient audiences. Winlevi works by targeting acne caused by a change in hormones by going after the root cause of most acne. The campaign was to introduce audiences to the first and only FDA-approved androgen receptor inhibitor, and the first new FDA-approved acne therapy in nearly 40 years—by highlighting this new approach to therapy for all skin types and ages.